Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology Industry by Canadian Healthcare Marketing Hall of Fame

Sanofi Pasteur's Mark Lievonen Honoured For Commitment to Biotechnology 
Industry by Canadian Healthcare Marketing Hall of Fame 
30-year Industry Veteran Advocate for Advancing Science, Innovation and 
Canadian Competitiveness 
TORONTO, April 11, 2013 /CNW/ - Mark Lievonen, President of Sanofi Pasteur 
Limited, the Canadian vaccine division of the Sanofi Group, has been inducted 
into the 2013 Canadian Marketing Healthcare Hall of Fame Award, in recognition 
of his outstanding contributions to the healthcare industry. 
The Canadian Healthcare Marketing Hall of Fame was established in 1988 to 
honour lifetime achievement in healthcare marketing. This award is the 
highlight of the annual National Pharmaceutical Congress organized by the 
Chronicle Companies. 
"Through a career spanning over 30 years, Mark Lievonen has made a lasting 
impact on the industry and served as a source of inspiration to others," said 
Mitchell Shannon, Publisher, The Chronicle Newspapers, which sponsors the 
award. "The judging committee was impressed by Mr. Lievonen's extraordinary 
dedication and commitment to the profession. Under his leadership, Sanofi 
Pasteur has become a billion dollar enterprise in Canada, and is a symbol of 
Canadian talent, innovation and R&D excellence." 
Lievonen is an active member in the life sciences sector. He is a member of 
several organizations, notably: Director, Oncolytics Biotech Inc.; Vice-Chair, 
Ontario Institute for Cancer Research; First Vice-Chair, Rx&D; Chair, Markham 
Stouffville Hospital Foundation; Director, Public Policy Forum; Governor, York 
University; Director, BIOTECanada; Director, Markham Stouffville Hospital; and 
Director, York University Development Corporation. 
"I am truly honoured to receive this recognition on behalf of Sanofi Pasteur, 
my colleagues and my community, and I am proud that we have been able to play 
a small part in preventing disease and saving lives in Canada and all around 
the world," says Mark Lievonen. "I am energized by the work we do, inspired 
by my passionate colleagues and humbled by our role in impacting human lives 
each and every day." 
Lievonen has been the recipient of the Queen's Golden Jubilee Medallion 
(2002), the Chevalier de l'Ordre National de Mérite by the Government of 
France (2007), Fellow, Ontario Institute of Chartered Accountants (2009) and 
received the Queen's Diamond Jubilee Medallion (2012). Twenty years ago, 
Lievonen also spearheaded Canada's only mentored science competition, the 
Sanofi BioGENEius Challenge Canada (SBCC), to foster biotechnology talent in 
Canada among high school students. For a complete biography click here. 
Mark Lievonen joined Sanofi Pasteur Canada in 1983 and has been the President 
since 1999. For almost 100 years, Sanofi Pasteur has been at the forefront of 
innovation in vaccine R&D, and has made more than $600 million in capital 
expenditures since 2000. The company manufactures over 50 million doses of 
vaccines in Canada for both domestic and international markets, and is the 
only manufacturer of 5-component acellular pertussis combination vaccines, 
which was launched in Canada as Pentacel® in 1997. Sanofi Pasteur has a 
broad vaccine portfolio in Canada, including Pediacel®, Menactra®, Adacel®, 
Intanza®, Vaxigrip®, ViVaxim®, Typhim Vi® and YF-Vax®. 
Nominations for the 2013 selection of honorees were solicited during the past 
months from the publication's readers. Since 1988, 95 healthcare 
visionaries, original thinkers and leaders have been honoured with this 
prestigious distinction. Numerous submissions were received and a committee 
consisting of the publications' editors and an ad hoc group of industry 
advisors undertook the difficult task of determining from among the Nominees 
the candidates who best exemplified the qualities described above, based on 
the information submitted by the individual(s) making the nomination. 
About Sanofi 
Sanofi, a global and diversified healthcare leader, discovers, develops and 
distributes therapeutic solutions focused on patients' needs. Sanofi has core 
strengths in the field of healthcare with seven growth platforms: diabetes 
solutions, human vaccines, innovative drugs, rare diseases, consumer 
healthcare, emerging markets and animal health. Sanofi is listed in Paris 
(EURONEXT: SAN) and in New York (NYSE: SNY). 
Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion 
doses of vaccine each year, making it possible to immunize more than 500 
million people across the globe. A world leader in the vaccine industry, 
Sanofi Pasteur offers the broadest range of vaccines protecting against 20 
infectious diseases. The company's heritage, to create vaccines that protect 
life, dates back more than a century. Sanofi Pasteur is the largest company 
entirely dedicated to vaccines. Every day, the company invests more than EUR 1 
million in research and development. For more information, please visit: 
Media Contacts: Nancy Simpson Sanofi Pasteur Tel: 416-667-2955 
Kara LATTA CASACOM Tel: 416-944-2145 
Image with caption: "Mark Lievonen, President, Sanofi Pasteur Limited is 
inducted into the Canadian Healthcare Marketing Hall of Fame Award by Mitchell 
Shannon, Publisher, The Chronicle Newspapers at the Canadian Pharmaceutical 
Congress, held yesterday at the Mississauga Convention Centre. (CNW 
Group/Sanofi Pasteur Inc.)". Image available at: 
SOURCE: Sanofi Pasteur Inc. 
To view this news release in HTML formatting, please use the following URL: 
CO: Sanofi Pasteur Inc.
ST: Ontario
-0- Apr/11/2013 17:13 GMT
Press spacebar to pause and continue. Press esc to stop.